Sana Biotechnology Inc. (SANA)
NASDAQ: SANA
· Real-Time Price · USD
3.40
0.07 (2.10%)
At close: Aug 18, 2025, 3:59 PM
2.10% (1D)
| Bid | 3.33 |
| Market Cap | 765.76M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -208.67M |
| EPS (ttm) | -1.06 |
| PE Ratio (ttm) | -3.2 |
| Forward PE | -4.1 |
| Analyst | Buy |
| Ask | 3.4 |
| Volume | 4,637,428 |
| Avg. Volume (20D) | 5,661,875 |
| Open | 3.33 |
| Previous Close | 3.33 |
| Day's Range | 3.27 - 3.48 |
| 52-Week Range | 1.26 - 7.30 |
| Beta | 1.91 |
About SANA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SANA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SANA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
-30.12%
Sana Biotechnology shares are trading lower after ...
Unlock content with
Pro Subscription
5 months ago
-17.69%
Sana Biotechnology shares are trading lower. The company reported Q4 financial results.
3 months ago · seekingalpha.com
Sana: HIP-Modified Islet Cells To Possibly Change Scope Of Type 1 Diabetes TreatmentData from phase 1 studies using SC291 to treat patients with B-cell mediated autoimmune disorders and SC262 for patients with relapsed/refractory B-cell malignancies expected in 2025. First-in-human s...
